A lot could happen on the trade front in the next few weeks, from pressuring Russia on Ukraine to arguing the legality of the ...

President Trump and his administration have been studying new sectoral tariffs that could cover a broad part of the American ...

President Donald Trump is readying plans for industry-specific tariffs to kick in alongside his country-by-country duties in ...

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...

President Trump is reportedly pushing for higher blanket tariffs on imports from the European Union, throwing a wrench in ...

Despite former President Donald Trump’s threat of a 200% tariff on imported drugs during a cabinet meeting, pharmaceutical investors have shown surprisingly positive sentiment this week. Despite ...

The Treasurer says he is evaluating the impact of US drug tariffs on the Pharmaceutical Benefits Scheme but says subsidies ...

In addition to measures on copper, the U.S. has discussed making announcements on lumber, chips, critical minerals and drugs ...

Amgen Inc. (NASDAQ:AMGN) is one of the high-margin pharma stocks to buy now. HSBC has lowered its price target on Amgen Inc.

CIO & PM of leading sector ETF explains what has been impacting leading names and why he still sees strong long-term ...

Exporters from engineering, plastics and pharmaceuticals said delayed tariff decisions from Washington had stalled expansion plans, pushed back new US orders and clouded short-term growth.

The average consumer could also pay 75 percent more for a marketplace plan, according to a KFF analysis, driven by the ...